MENSA, a Media Enriched with Newly Synthesized Antibodies, to Identify SARS-CoV-2 Persistence ... Viral Reactivation in Long-COVID, 2024, Haddad+

[EndME]

MENSA is one of the tests that is taking part in the PolyBio VIPER study. So we should see results from that in a year, I think.

Possibly, but Polybio projects frequently don't report results when they are negative and I don't think anybody is particularly positive that any of their first 5 platforms tested will yield anything sensible.